Skip to content

Optimalization of real-time intraoperative near-infrared (NIR) fluorescence cholangiography during laparoscopic cholecystectomy

Fluorescence cholangiography: dose and time optimzation study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23566
Enrollment
28
Registered
2016-01-07
Start date
2014-11-13
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intraoperative clarification of bile duct anatomy using NIR fluorescence imaging

Interventions

Patients will be divided in several groups and receive either 5 or 10 mg ICG, administered (iv)30 min, 2h, 4h, 6h or 24 hours prior to surgery. Standard laparoscopic cholecystectomy will be performed.

Sponsors

Leiden University Medical Center (LUMC)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients (>18 years old) suffering from benign gallbladder pathology, planned to undergo laparoscopic cholecystectomy

Exclusion criteria

Exclusion criteria: 1. Allergy for jodide or indocyanine green; 2. Hyperthyroidism or autonomous thyroidal adenoma; 3. Pregnancy; 4. Severe renal impairment (eGFR<55)

Design outcomes

Primary

MeasureTime frame
- Identification of bile ducts using laparoscopic NIR fluorescence imaging during laparoscopic cholecystectomy.

Secondary

MeasureTime frame
-Distinctive character of fluorescence imaging of bile ducts vs. liver after injection of either 5 or 10 mg ICG after several time points -Evaluation of applicability of NIR fluorescence imaging during laparoscopic cholecystectomy by performing questionnaire after surgery

Contacts

Public ContactC.J.H. Velde, van de

Leiden University Medical Center (LUMC), Department of Surgical Oncology, P.O. Box 9600

c.j.h.van_de_velde@lumc.nl+31 (0)71 5262309

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)